loe 908 has been researched along with snx 230 in 1 studies
| Studies (loe 908) | Trials (loe 908) | Recent Studies (post-2010) (loe 908) | Studies (snx 230) | Trials (snx 230) | Recent Studies (post-2010) (snx 230) |
|---|---|---|---|---|---|
| 50 | 0 | 5 | 226 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furutani, H; Hasegawa, H; Iwamuro, Y; Lee, K; Masaki, T; Miwa, S; Morita, H; Nakagawa, T; Okamoto, Y; Zhang, XF | 1 |
1 other study(ies) available for loe 908 and snx 230
| Article | Year |
|---|---|
Pharmacological characterization of receptor-mediated Ca2+ entry in endothelin-1-induced catecholamine release from cultured bovine adrenal chromaffin cells.
Topics: Acetamides; Adrenal Glands; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cattle; Cells, Cultured; Chromaffin Cells; Dose-Response Relationship, Drug; Endothelin-1; Epinephrine; Imidazoles; Inhibitory Concentration 50; Ion Channels; Isoquinolines; Linear Models; Nifedipine; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Receptor, Endothelin A; Receptors, Endothelin; Signal Transduction | 1999 |